View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United Kingdom |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2043-03-18 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 500.00 |
| Coupon | 4.2 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 500 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Glaxosmithkline Capital Inc corporate note has a 4.20% fixed rate coupon paid on a semi-annual basis. It was issued on March 18, 2013 with an issue size of 500.00 million USD and matures on March 18, 2043 with a last coupon date of September 18, 2042. |
GlaxoSmithKline Capital Inc, founded in 2000 and headquartered in London, UK, serves as the financing arm of the global healthcare company GlaxoSmithKline plc. The company focuses on providing capital to support its parent’s extensive pharmaceutical and consumer healthcare product lines.